Silicon BioDevices, Inc. is leveraging the superior functionality and intuitive experience of digital microchip technology in a new generation of Point-of-Care (POC) in vitro diagnostic devices. The Company is commercializing a disposable blood analyzer based on a proprietary CMOS chip which is capable of performing accurate biomarker tests in minutes, with no external reader. This technology provides a compelling alternative to cumbersome lab tests, and existing "POC" tests which are inaccurate, difficult to use, and require cumbersome and costly readers. The Company's first product, the HeartScreen™, enables physicians to accurately measure cardiac biomarkers to diagnose heart attacks on the spot as patients present to emergency departments, a $1.1B market in the US.